Pune: Emcure Pharmaceuticals Limited has announced the incorporation of a new wholly-owned subsidiary named Emcure Wellness Private Limited. The new entity was officially incorporated on July ...

Emcure Pharma stock was quoting at ₹1,382.5, up 1.5 per cent from the previous day's close of ₹1,362.5 as the company ...

Pune: Emcure Pharma has announced the appointment of R.S. Vasan as President - India Business and Senior Management Personnel ...

Emcure signs exclusive agreement with Sanofi India to distribute and promote its oral anti-diabetic brands Amaryl and Cetapin ...

The partnership enhances Emcure’s existing diabetes portfolio and reinforces its efforts to expand access to affordable, high ...

Emcure Pharmaceuticals and Sanofi India have announced a distribution agreement. Emcure will promote Sanofi India's oral anti ...

Emcure Pharmaceuticals Limited announced the appointment of Mr. R.S. Vasan as President - India Business and Senior ...

KPRDO acknowledges Emcure’s positive response on exclusive stockist appointment for special category sales: Nandita ...

Emcure Pharmaceuticals IPO saw positive investor response with overwhelming demand, offering new equity shares valued at ₹800 crore and existing shareholders issuing 1.14 crore equity shares in ...

Emcure Pharmaceuticals and Sanofi India have partnered in an exclusive distribution and promotion agreement for Sanofi's oral ...

Emcure Pharmaceuticals Ltd. continues to strengthen its leadership with appointment of distinguished professionals to its board of directors. ETHealthWorld Updated On Jul 28, 2021 at 07:44 AM IST ...

6.Emcure Pharmaceuticals IPO reservation: Emcure Pharma IPO has reserved not more than 50 per cent of the shares in the public issue for qualified institutional buyers (QIB), not less than 15 per ...